Corcept Therapeutics Incorporated (CORT)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 506,705 | 501,842 | 375,806 | 523,338 | 371,182 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $506,705K
= 0.00
The debt-to-equity ratio for Corcept Therapeutics Inc has consistently been 0.00 for the past five years, from 2019 to 2023. This indicates that the company has not utilized debt to finance its operations and has relied solely on equity for funding. A debt-to-equity ratio of 0.00 suggests a conservative capital structure with a low level of financial leverage, which can be viewed positively by investors and creditors as it implies lower financial risk. However, it is important to note that a very low debt-to-equity ratio may also limit the company's ability to take advantage of leverage for potential growth opportunities. Overall, a consistent 0.00 debt-to-equity ratio over the years reflects Corcept Therapeutics Inc's stable financial position and conservative approach to capital structure management.
Peer comparison
Dec 31, 2023